Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) EBIT (2016 - 2025)

United Health Products (UEEC) has disclosed EBIT for 15 consecutive years, with -$233179.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBIT rose 40.5% to -$233179.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.8 million, a 66.35% decrease, with the full-year FY2024 number at -$2.0 million, up 17.27% from a year prior.
  • EBIT was -$233179.0 for Q3 2025 at United Health Products, up from -$268356.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$233179.0 in Q3 2025 to a low of -$26.7 million in Q1 2021.
  • A 5-year average of -$2.1 million and a median of -$553563.0 in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: tumbled 4181.01% in 2021, then soared 96.43% in 2022.
  • United Health Products' EBIT stood at -$1.1 million in 2021, then surged by 48.31% to -$553563.0 in 2022, then rose by 19.31% to -$446657.0 in 2023, then crashed by 75.84% to -$785398.0 in 2024, then soared by 70.31% to -$233179.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's EBIT are -$233179.0 (Q3 2025), -$268356.0 (Q2 2025), and -$1.5 million (Q1 2025).